Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-15-048133

Options or other derivatives

  • President and CEO acquired 375,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schwieterman William D President and CEO 2015-05-28 Grant or award · Employee Stock Option (Right to Buy) +75,000 75,000 D
Schwieterman William D President and CEO 2015-05-28 Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X03/doc4.xml…